Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 16/07/19981 min de lecture
Draft Guidance for Industry on Labeling of OTC Topical Drug Products for the Treatment of Vaginal Yeast Infections (Vulvovaginal Candidiasis); Availability
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Labeling Guidance for OTC Topical Drug Products for the Treatment of Vaginal Yeast Infections (Vulvovaginal Candidiasis).'' The guidance is intended to provide a general labeling format for all over-the-counter (OTC) drug products for the treatment of vaginal yeast infections. The draft guidance provides recommendations for both the carton and the educational brochure.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →